Monographie - Amoxicillin sodium

Senaste uppdateringen :
19/11/2024

Amoxicillin sodium

Molekylstruktur

Varunamn

Angivna handelsnamn på läkemedel är enbart vägledande då formulering inklusive hjälpämnen kan variera mellan länder och tillverkare

Alfoxil	Turkiet
Allmox	Indien
Amitron	Spanien
Amocillin	Sydafrikanska republiken
Amodex	Marocko
Amofluxin	Egypten
Amoxicilin	Peru, Storbritannien
Amoxicillina	Italien
Amoxidal	Argentina, Peru
Amoxil	Australien, Egypten, Grekland, Irland, Marocko, Portugal, Saudi-Arabien, Storbritannien, Tunisien
Aximycine	Marocko, Tunisien
Bactox	Frankrike, Marocko
Biomox	Egypten
Clamoxyl	Belgien, Frankrike, Luxemburg, Marocko, Nederländerna, Schweiz, Spanien
Darzitil	Argentina
E-Mox	Egypten
Farconcil	Egypten
Fisamox	Australien
Flemoxin	Nederländerna
Glymox Plus	Indien
Ibiamox	Italien, nya Zeeland
Klomox	Indien
Largopen	Turkiet
Magcil	Indien
Mixcilin	Argentina
Moxacin	Australien
Moxilen	Tunisien
Moxynil	Egypten
Novabritine	Luxemburg
Pamocil	Italien
Penamox	Marocko, Mexiko
Simplamox	Italien
Velamox	Italien

Hänvisningar : Amoxicillin sodium

	Typ	Publikation
186	tidningen	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
427	tidningen	Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB. Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states. Am J Hosp Pharm 1986 ; 43: 3027-3030.
598	tidningen	Mc Donald C, Sunderland VB, Lau H, Shija R. The stability of amoxycillin sodium in normal saline and glucose (5%) solutions in the liquid and frozen states. J Clin Pharm Ther 1989 ; 14: 45-52.
889	tidningen	Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM. Ofloxacin intravenous. Compatibility with other antibacterial agents. Pharm Weekbl [Sci] 1991 ; 13: 207-209.
939	tidningen	Gilbar PJ, Groves CF. Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection. Aust J Hosp Pharm 1994 ; 24: 167-170.
1333	tidningen	Cook B, Hill SA, Lynn B. The stability of amoxycillin sodium in intravenous infusion fluids. J Clin Hosp Pharm 1982 ; 7: 245-250.
1357	tidningen	Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM. Quinolones and penicillins incompatibility. Ann Pharmacotherapy 1989 ; 23: 91-92.
1845	tidningen	Müller HJ, Haker I. The stability of amoxicillin, ampicillin, benzylpenicillin, flucloxacillin, mezlocillin and piperacillin in isotonic saline solutions when stored in an innovative infusion container (Freeflex container). EJHP 2003 ; 6: 106-111.
1888	tidningen	Janknegt R, Van den Berg TJ, De Jong M, Oldenhof HGJ, Steenhoek A. Compatibility study of midazolam. Ziekenhuisfarmacie 1986 ; 2: 45-48.
2349	tidningen	Pourroy B, Milano Bausset E, Boulamery A, Gauthier Villano L, Braguer B. Incompatibility of imipenem–cilastatin and amoxicillin Am J Health-Syst Pharm 2009 ; 66: 1253-1254.
3227	tidningen	Simon B, Hancu G, Gy?resi A. Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520	Laboratorium	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3527	Laboratorium	Amoxicillin (Amoxil®) – Summary of Product Characteristics Glaxo Smith Kline 2018
3529	Laboratorium	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3549	Laboratorium	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3564	Laboratorium	Rocuronium B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laboratorium	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratorium	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3728	tidningen	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3777	tidningen	Patel R.P, Li K, Shastri M, Wanandy T, Jose M.D. Stability of ampicillin and amoxicillin in peritoneal dialysis solutions Am J Health-Syst Pharm 2015 ; 72:13-14
4211	tidningen	Binson G, Grignon C, Le Moal G, Lazaro P, Lelong J, Roblot F, Venisse N, Dupuis A. Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps. PlosOne 2019
4254	tidningen	D'Huart E, Vigneron J, Demoré B. Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40
4634	tidningen	Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 2022 ;11,4: 458
4654	affisch	Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R. Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 2021
4837	tidningen	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales